G01N 33/564
For pre-existing immune complex or autoimmune disease , i.e. systemic lupus erythematosus
Official title: for pre-existing immune complex or autoimmune disease {, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9}
G01N33/564 (For pre-existing immune complex or autoimmune disease , i.e. systemic lupus erythematosus) appears on 1,651 US grants and 2,784 published applications in this corpus.
Search patents in G01N- Granted patents
- 1,651
- Published applications
- 2,784
- Assignees
- 1,327
- Inventors
- 5,232
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 5 | 0 |
| 1980 | 6 | 0 |
| 1981 | 7 | 0 |
| 1982 | 7 | 0 |
| 1983 | 3 | 0 |
| 1984 | 7 | 0 |
| 1985 | 6 | 0 |
| 1986 | 7 | 0 |
| 1987 | 14 | 0 |
| 1988 | 14 | 0 |
| 1989 | 11 | 0 |
| 1990 | 8 | 0 |
| 1991 | 9 | 0 |
| 1992 | 9 | 0 |
| 1993 | 20 | 0 |
| 1994 | 16 | 0 |
| 1995 | 23 | 0 |
| 1996 | 20 | 0 |
| 1997 | 22 | 0 |
| 1998 | 50 | 0 |
| 1999 | 28 | 0 |
| 2000 | 25 | 0 |
| 2001 | 29 | 13 |
| 2002 | 18 | 41 |
| 2003 | 22 | 77 |
| 2004 | 31 | 73 |
| 2005 | 28 | 95 |
| 2006 | 34 | 112 |
| 2007 | 33 | 96 |
| 2008 | 29 | 99 |
| 2009 | 36 | 118 |
| 2010 | 60 | 116 |
| 2011 | 75 | 124 |
| 2012 | 62 | 128 |
| 2013 | 62 | 135 |
| 2014 | 50 | 134 |
| 2015 | 75 | 125 |
| 2016 | 62 | 139 |
| 2017 | 74 | 176 |
| 2018 | 77 | 111 |
| 2019 | 78 | 137 |
| 2020 | 78 | 140 |
| 2021 | 68 | 117 |
| 2022 | 65 | 103 |
| 2023 | 50 | 111 |
| 2024 | 49 | 110 |
| 2025 | 49 | 88 |
| 2026 | 38 | 66 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for detection of pathogenic antiphospholipid antibodies and for identification of inhibitors29 Sep 2026US 12,748,111 B2The Scripps Research Institute
- Method for diagnosing autoimmune gastritis15 Sep 2026US 12,736,532 B2EUROIMMUN Medizinische Labordiagnostika AG
- Antibody tests for identifying Ro negative Sjogren's Syndrome and use as biomarkers for dysregulated B cell responses, B cell lymphoma, tissue fibrosis and salivary gland dysfunction15 Sep 2026US 12,736,533 B2Oklahoma Medical Research Foundation
- Method for monitoring autoimmune disease8 Sep 2026US 12,730,106 B2The Regents of the University of Micigan
- CD8 binding agents and uses thereof25 Aug 2026US 12,715,920 B2Genentech, Inc.
- Methods for Verification of Drug Levels Using Dried Blood Samples8 Oct 2026US 2026/0309705 A1Sanofi
- Early detection and monitoring of neurodegenerative diseases using a multidisease diagnostic platform8 Oct 2026US 2026/0309723 A1Durin Life Sciences, Inc.
- Staining kit and method for assessing likelihood of rheumatoid arthritis disease risk using the same1 Oct 2026US 2026/0298923 A1
- Quantitative immunoassay for the detection of autoantibodies to nephrin1 Oct 2026US 2026/0298924 A1EUROIMMUN Medizinische Labordiagnostika AG
- Methods of detecting and quantifying autoantibodies against neuronal antigens17 Sep 2026US 2026/0276635 A1Uni Pharma Co., Ltd.
Most cited
By later US patents
- Solid phase anti-C3 assay for detection of immune complexes162US 4,342,566 AScripps Clinic and Research Foundation · 1982
- Selective removal of immunospecifically recognizable substances from solution156US 4,551,435 AImmunicon Corporation · 1985
- Antibodies that immunospecifically bind BLyS113US 7,138,501 B2Human Genome Sciences, Inc. · 2006
- Method for identifying T cells disease involved in autoimmune disease97US 5,298,396 ANational Jewish Center for Immunology and Respiratory Medicine · 1994
- Synthetic peptide and its uses95US 5,698,449 ANorthwestern University · 1997